En esta oportunidad se adicionan artículos relevantes para la rotación del Estudiante de 10mo Semestre de medicina Mateo Mejía y Valentina Estupiñán. Hay un sesgo hacia estudios de ciencia básica que son un nuevo foco de interés de quien hace la página.
ESMO's Clinical Handbooks
ESMO's Clinical Handbook of Cancer Treatments in Special Clinical Situations (2013)
ESMO's Clinical Handbook of Cancer Chemotherapy (2012)
ESMO'S Clinical Handbook of Nutrition and Cancer (2011)
EMOS's Clinical Handbook Cancer in the Senior Patient (2010)
Basic Science and Translational Medicine
Breast Cancer Stem-Cells
Nature Reviews Key Advances 2012
Nature Reviews anti Her2 resistance Mechanisms in BC
Basic Science: Hallmarks of Cancer, Cell, 2000
Basic Science: Hallmarks of Cancer - Next Generation, Cell, 2011
Basic Science: How to make a cancer cell
Basic Science: Description of EGFR mutation in NSCLC
Basic Science: Anti EGFR and Anti BRAF in CRC
Basic Science: MGMT and Temozolomide in GBM
Basic Science: p53 nuclear accumulation in Bladder Cancer
Basic Science: DNA microarray in DLBCL
Basic Science: Burkit vs DLBCL
Hematology Oncology
Cheson criteria for response in NHL
How I Treat CLL
Stil: Bendamustina + Rituximab en Fol NHL
Ruxolitinib in MyeloFibrosis
Ruxolitinib in Myelofibrisis 1
Arsenic Trioxide in APL
BPDCN: Series of 90 patients
Blastic Plasmocytoid Dendriti Cell Neoplasm
BPDCN with leukemic presentation: an Italian multicenter study
L-Asp + Methtrexate + Dexametasone in BPDCN
Solid Tumor Oncology
CNS Oncology
Stupp: Chemoradiation with Temozolomide in GBM
De Angelis in Primary CNS Lymphoma
Head and Neck cancer
Induction Cisp+FU+Paclitaxel in Advanced H&N Ca
Breast cancer
ATLAS: Adjuvant Tamoxifén 5 vs 10 yrs
CLEOPATRA: Pertuzumab + Trastuzumab + Docetaxel in 1st-Line Her2+ mBC
Lung cancer
Pemetrexed + Carboplatin vs Pemetrexed in PS2 mNSCLC
PCI in SCLC
Pancreatic cancer
Nab-Paclitaxel + Gemcitabine a New Standard of Care in Pancreatic Cancer
Colorectal cancer
MOSAIC: Adjuvant FOLFOX in stage II, III CRC
MOSAIC: FOLFOX vs FULV in HR Stage II or 70+
Review: PreOperative ChemoRT in Rectal Ca (2010)
Review: Rectal cancer - State of the Art (2012)
Preoperative vs Postoperative chemo-RT in Rectal Cancer
Oxaliplatin + FP before and after surgery in Rectal Cancer
BICC: FOLFIRI-Bev mCRC 1st-line
Renal-cell cancer
COMPARZ: Pazopanib less toxic than Sunitinib
Prostate cancer
Abiraterone in CRPC prior to Docetaxel
Abiraterone Post Docetaxel in CRPC
Enzalutamide in Post Docetaxel mProstate Cancer
Soft-tissue sarcoma
Trabectedin in Myxoid Lyposarcoma
Osteosarcoma
Protocolo de Osteosarcoma
GIST
Choi criteria for response evaluation in GIST
Adjuvant Imatinib in Resected GIST
Imatinib in Metastatic GIST
Imatinib effective in Exon 11 c-Kit mutation in Metastatic GIST
Sunitinib in Imatinib Refractory/Intolerant in Advanced GIST
Regorafenib after Imatinib / Sunitinib in Advanced GIST
Carcinoma anaplásico de tiroides
Guía de manejo de carcinoma anaplásico de tiroides
Revisión de carcinoma anaplásico de tiroides
Miscellaneous
Vía subcutánea - Guías SECPAL
Olanzapine is Non-Inferior to Aprepitant in CINV
Clinical diagnostic reasoning
Bad news delivery and the SPIKES Method
Videos Mauricio Lema
Cancer of Unknown Primary Site - CUPS - Video
Terapia adyuvante para cáncer de mama - Video
Innovación en Oncología
Otros documentos - Mauricio lema
CapacitacionMelanoma